| Predicate |
Object |
| contentType |
Journal Article|Research Support, U.S. Gov't, P.H.S.|Review |
| endingPage |
89 |
| issn |
1064-3745 |
| pageRange |
169-89 |
| publicationName |
Methods in molecular biology (Clifton, N.J.) |
| startingPage |
169 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ed00f6f701cf214c8332a5f576c006bf
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e8a02e80a48123775ce8d8687e3aeac0
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f820a6b2b1a82a8d42f9f523137eda4d |
| bibliographicCitation |
Dignam J, Bryant J, Paik S. Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy. Methods Mol Biol. 2002;184():169–89. doi: 10.1385/1-59259-242-2:169. PMID: 11889713. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9688-6480
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dab917d2db352295aa1d5e1e38d8a608
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fb121702659a1a5f307911ea97ed1a6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04bd0609f72ffc7b05240f1f26a87992 |
| date |
2002 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/11889713
https://doi.org/10.1385/1-59259-242-2:169 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2488
https://portal.issn.org/resource/ISSN/1064-3745 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy |
| discusses |
http://id.nlm.nih.gov/mesh/M0022149 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001699Q000379
http://id.nlm.nih.gov/mesh/D009369Q000628
http://id.nlm.nih.gov/mesh/D015233
http://id.nlm.nih.gov/mesh/D014408
http://id.nlm.nih.gov/mesh/D009369Q000175 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D011237 |